Literature DB >> 21986237

Docking studies of benzylidene anabaseine interactions with α7 nicotinic acetylcholine receptor (nAChR) and acetylcholine binding proteins (AChBPs): application to the design of related α7 selective ligands.

David C Kombo1, Anatoly Mazurov, Kartik Tallapragada, Philip S Hammond, Joseph Chewning, Terry A Hauser, Montserrat Vasquez-Valdivieso, Daniel Yohannes, Todd T Talley, Palmer Taylor, William S Caldwell.   

Abstract

AChBPs isolated from Lymnaea stagnalis (Ls), Aplysia californica (Ac) and Bulinus truncatus (Bt) have been extensively used as structural prototypes to understand the molecular mechanisms that underlie ligand-interactions with nAChRs [1]. Here, we describe docking studies on interactions of benzylidene anabaseine analogs with AChBPs and α7 nAChR. Results reveal that docking of these compounds using Glide software accurately reproduces experimentally-observed binding modes of DMXBA and of its active metabolite, in the binding pocket of Ac. In addition to the well-known nicotinic pharmacophore (positive charge, hydrogen-bond acceptor, and hydrophobic aromatic groups), a hydrogen-bond donor feature contributes to binding of these compounds to Ac, Bt, and the α7 nAChR. This is consistent with benzylidene anabaseine analogs with OH and NH(2) functional groups showing the highest binding affinity of these congeners, and the position of the ligand shown in previous X-ray crystallographic studies of ligand-Ac complexes. In the predicted ligand-Ls complex, by contrast, the ligand OH group acts as hydrogen-bond acceptor. We have applied our structural findings to optimizing the design of novel spirodiazepine and spiroimidazoline quinuclidine series. Binding and functional studies revealed that these hydrogen-bond donor containing compounds exhibit improved affinity and selectivity for the α7 nAChR subtype and demonstrate partial agonism. The gain in affinity is also due to conformational restriction, tighter hydrophobic enclosures, and stronger cation-π interactions. The use of AChBPs structure as a surrogate to predict binding affinity to α7 nAChR has also been investigated. On the whole, we found that molecular docking into Ls binding site generally scores better than when a α7 homology model, Bt or Ac crystal structure is used.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21986237      PMCID: PMC4791960          DOI: 10.1016/j.ejmech.2011.09.033

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  36 in total

1.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.

Authors:  Thomas A Halgren; Robert B Murphy; Richard A Friesner; Hege S Beard; Leah L Frye; W Thomas Pollard; Jay L Banks
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

2.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

Review 3.  Selective alpha7 nicotinic acetylcholine receptor ligands.

Authors:  Anatoly Mazurov; Terry Hauser; Craig H Miller
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

4.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

Authors:  Richard A Friesner; Robert B Murphy; Matthew P Repasky; Leah L Frye; Jeremy R Greenwood; Thomas A Halgren; Paul C Sanschagrin; Daniel T Mainz
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

5.  Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.

Authors:  Jotham W Coe; Paige R Brooks; Michael G Vetelino; Michael C Wirtz; Eric P Arnold; Jianhua Huang; Steven B Sands; Thomas I Davis; Lorraine A Lebel; Carol B Fox; Alka Shrikhande; James H Heym; Eric Schaeffer; Hans Rollema; Yi Lu; Robert S Mansbach; Leslie K Chambers; Charles C Rovetti; David W Schulz; F David Tingley; Brian T O'Neill
Journal:  J Med Chem       Date:  2005-05-19       Impact factor: 7.446

6.  Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors.

Authors:  A R Davies; D J Hardick; I S Blagbrough; B V Potter; A J Wolstenholme; S Wonnacott
Journal:  Neuropharmacology       Date:  1999-05       Impact factor: 5.250

7.  Crystal structure of acetylcholine-binding protein from Bulinus truncatus reveals the conserved structural scaffold and sites of variation in nicotinic acetylcholine receptors.

Authors:  Patrick H N Celie; Remco V Klaassen; Sarah E van Rossum-Fikkert; René van Elk; Pim van Nierop; August B Smit; Titia K Sixma
Journal:  J Biol Chem       Date:  2005-05-16       Impact factor: 5.157

8.  Surface plasmon resonance biosensor based fragment screening using acetylcholine binding protein identifies ligand efficiency hot spots (LE hot spots) by deconstruction of nicotinic acetylcholine receptor α7 ligands.

Authors:  Gerdien E de Kloe; Kim Retra; Matthis Geitmann; Per Källblad; Tariq Nahar; René van Elk; August B Smit; Jacqueline E van Muijlwijk-Koezen; Rob Leurs; Hubertus Irth; U Helena Danielson; Iwan J P de Esch
Journal:  J Med Chem       Date:  2010-10-14       Impact factor: 7.446

9.  Spectroscopic analysis of benzylidene anabaseine complexes with acetylcholine binding proteins as models for ligand-nicotinic receptor interactions.

Authors:  Todd T Talley; Samar Yalda; Kwok-Yiu Ho; Yitzhak Tor; Ferene S Soti; William R Kem; Palmer Taylor
Journal:  Biochemistry       Date:  2006-07-25       Impact factor: 3.162

10.  Use of acetylcholine binding protein in the search for novel alpha7 nicotinic receptor ligands. In silico docking, pharmacological screening, and X-ray analysis.

Authors:  Chris Ulens; Atilla Akdemir; Aldo Jongejan; Rene van Elk; Sonia Bertrand; Anastassis Perrakis; Rob Leurs; August B Smit; Titia K Sixma; Daniel Bertrand; Iwan J P de Esch
Journal:  J Med Chem       Date:  2009-04-23       Impact factor: 7.446

View more
  3 in total

1.  Efficient expression of acetylcholine-binding protein from Aplysia californica in Bac-to-Bac system.

Authors:  Bo Lin; Hailing Meng; Hui Bing; Dongting Zhangsun; Sulan Luo
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

2.  Competitive docking model for prediction of the human nicotinic acetylcholine receptor α7 binding of tobacco constituents.

Authors:  Hui Wen Ng; Carmine Leggett; Sugunadevi Sakkiah; Bohu Pan; Hao Ye; Leihong Wu; Chandrabose Selvaraj; Weida Tong; Huixiao Hong
Journal:  Oncotarget       Date:  2018-02-08

3.  Palladium-Catalyzed α-Arylation of Cyclic β-Dicarbonyl Compounds for the Synthesis of CaV1.3 Inhibitors.

Authors:  Jisu Yun; Dayeon Jeong; Zhong Xie; Sol Lee; Jiho Kim; D James Surmeier; Richard B Silverman; Soosung Kang
Journal:  ACS Omega       Date:  2022-04-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.